Hemoperitoneum after a<i> Bothrops</i> snakebite: Case report

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Autores
RIBEIRO, Adriana Baqueiro Abad
SANTORO, Marcelo Larami
DUARTE, Marcelo Ribeiro
VIRGULINO, Cristiana Cruz
Citação
TOXICON, v.237, article ID 107350, 5p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Snakebites are frequent in tropical countries. Brazil has an average of 27,000 cases per year, with a fatality rate of 0.5%, and the Bothrops genus is the most common causative agent, accounting for about 70-90% of the accidents. This report describes a case of human envenomation by a juvenile Bothrops jararaca snake in Sa similar to o Paulo, Brazil, in a 71 years-old man, previously healthy. He presented a life-threatening envenomation, which developed to severe hypotension, acute kidney injury and extensive peritoneal hemorrhage. The hemoperitoneum was diagnosed due to persistent hypotension associated with anemia, pain and gastrointestinal complaints. Abdominal Computed Tomography scans showed a moderate to large amount of presumable hematic material inside the abdominal cavity, predominantly in the perihepatic and perisplenic spaces. The intra-abdominal hemorrhage was not surgically addressed, and the patient was discharged 5 days after hospitalization, with the progressive absorption of the hemoperitoneum. Systemic bleeding is one of the complications and main causes of death in Bothrops envenomations. Acute peritoneal hemorrhage is one of these serious complications that must be carefully addressed since its management must take into account the risk of bleeding caused by toxins that affect hemostasis. The case described highlights the importance of early diagnosis and adequate management of this potentially fatal complication in snakebites.
Palavras-chave
Snakebite, Bothrops envenomation, Hemoperitoneum, Peritoneal hemorrhage, Case report
Referências
  1. Ahn JH, 2007, KOREAN J RADIOL, V8, P556, DOI 10.3348/kjr.2007.8.6.556
  2. Aldhafeeri S, 2022, INT J SURG CASE REP, V99, DOI 10.1016/j.ijscr.2022.107691
  3. Antunes TC, 2010, TOXICON, V56, P1443, DOI 10.1016/j.toxicon.2010.08.011
  4. Bourke LA, 2022, TOXINS, V14, DOI 10.3390/toxins14050297
  5. Butantan Instituto, 2022, Bula do soro antibotropico (pentavalente)
  6. Cunha FC, 2015, REV SOC BRAS MED TRO, V48, P633, DOI 10.1590/0037-8682-0084-2015
  7. de Castroa I, 2004, TOXICON, V43, P833, DOI 10.1016/j.toxicon.2004.03.015
  8. Diallo B, 2019, PAN AFR MED J, V32, DOI 10.11604/pamj.2019.32.70.17951
  9. Franca F.O.S., 2009, Animais peconhentos do Brasil: biologia, clinica e terapeutica dos acidentes, P81
  10. França FOS, 2003, T ROY SOC TROP MED H, V97, P312, DOI 10.1016/S0035-9203(03)90158-1
  11. Fundacao Nacional de Saude, 2001, Brasilia Manual de Diagnostico e Tratamento de Acidentes por Animais Peconhentos, V2a, P89
  12. Gomez E, 2022, ABDOM RADIOL, V47, P475, DOI 10.1007/s00261-021-03336-w
  13. Kim TY, 2021, WILD ENVIRON MED, V32, P78, DOI 10.1016/j.wem.2020.10.004
  14. Kini RM, 2016, TOXINS, V8, DOI 10.3390/toxins8100284
  15. Kumar S, 2012, TROP DOCT, V42, P116, DOI 10.1258/td.2011.110281
  16. Milani R, 1997, QJM-MON J ASSOC PHYS, V90, P323, DOI 10.1093/qjmed/90.5.323
  17. Ministerio da Saude, 2023, Acidente por Animais Peconhentos
  18. Ministerio da Saude, 2016, Secretaria de Vigilancia em Saude (CGDT/DEVIT/SVS/MS). Nota Informativa n 25. Nova abordagem ao tratamento em casos de acidentes por serpentes do grupo Bothrops (""jararacas"") e por escorpioes, em situacao de escassez de antivenenos
  19. Mora-Obando D, 2023, TOXICON, V221, DOI 10.1016/j.toxicon.2022.106983
  20. Mosquera A, 2003, NEUROLOGY, V60, P1577, DOI 10.1212/01.WNL.0000061614.52580.A1
  21. Albuquerque PLMM, 2020, J VENOM ANIM TOXINS, V26, DOI [10.1590/1678-9199-JVATITD-2019-0076, 10.1590/1678-9199-jvatitd-2019-0076]
  22. Rathod K, 2003, ABDOM IMAGING, V28, P820, DOI 10.1007/s00261-003-0020-3
  23. RIBEIRO LA, 1990, REV I MED TROP, V32, P436, DOI 10.1590/S0036-46651990000600008
  24. Roberts NLS, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-33627-9
  25. Senise LV, 2015, EXP BIOL MED, V240, P1528, DOI 10.1177/1535370215590818
  26. Silva FS, 2021, REV SOC BRAS MED TRO, V54, DOI 10.1590/0037-8682-0374-2020
  27. Sousa LF, 2021, TOXINS, V13, DOI 10.3390/toxins13110814
  28. Sousa LF, 2018, TOXINS, V10, DOI 10.3390/toxins10100411
  29. Sousa LF, 2017, J PROTEOMICS, V159, P32, DOI 10.1016/j.jprot.2017.03.003
  30. Delgado ABT, 2017, TOXICON, V132, P6, DOI 10.1016/j.toxicon.2017.03.015
  31. Valenta Jiri, 2021, Prague Med Rep, V122, P216, DOI 10.14712/23362936.2021.19
  32. van der Vlies CH, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-47
  33. Yakubu A., 2020, Sahel Med J, V23, P191
  34. 이지영, 2013, Acute and Critical Care, V28, P336